Chemokine CXCL10 (IP-10) is sufficient to trigger an immune response to injected antigens in a mouse model

Vaccine

Volumn 24, Issue 15, 2006, Pages 2987-2993

  Krathwohl, Mitchell D ^a,b   Anderson, Jodi L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Rosetta Stone Labs   (United States)

Author keywords

Chemokine; Cytotoxic T cell; Vaccination

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON ANTIBODY; GAMMA INTERFERON INDUCIBLE PROTEIN 10; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CELL STIMULATION; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFECT; IMMUNE RESPONSE; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; VACCINIA VIRUS;

ANIMALS; CHEMOKINES, CXC; CYTOTOXICITY, IMMUNOLOGIC; MICE; MICE, INBRED C57BL; OVALBUMIN; SKIN ULCER; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 33644912849     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.11.032     Document Type: Article

References (13)

1. V. Gangur, F.E. Simons, and K.T. Hayglass Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-{gamma} over IL-4 responses FASEB J 12 1998 705 713
2. A. Itano, S. McSorley, and R. Reinhardt Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity Immunity 19 2003 47 57
3. P. Brossart, and M.J. Bevan Presentation of exogenous protein antigens on major histocompatability complex class I molecules by dendritic cells: Pathway of presentation and regulation by cytokines Blood 90 1997 1594 1599
4. M. Matsuo, Y. Nagata, and E. Sato IFN-{gamma} enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation Proc Natl Acad Sci, USA 101 2004 14467 14472
5. D. Owen, A. Hill, and S. Argent Reaction of mouse strains to skin test for ectromelia using an allied virus as inoculum Nature 254 1975 598 599
6. D.C. Tscharke, and G.L. Smith A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae J Gen Virol 80 1999 2751 2755
7. L.J. Jones, M. Gray, S.T. Yue, R.P. Haugland, and V.L. Singer Sensitive determination of cell number using the CyQUANT(R) cell proliferation assay J Immunol Methods 254 2001 85 98
8. W. Wierda, D. Mehr, and Y. Kim Comparison of fluorchrome-labeled and 51-Cr-labeled targets for natural killer cytotoxicity assay J Immunol Methods 122 1989 15 24
9. R. Maze, B. Sherry, B. Kwon, A. Cerami, and H. Broxmeyer Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha J Immunol 149 1992 1004 1009
10. R. Xu, A.J. Johnson, D. Liggitt, and M.J. Bevan Cellular and humoral immunity against vaccinia virus infection of mice J Immunol 172 2004 6265 6271
11. I. Drexler, C. Staib, and W. Kastenmuller Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines Proc Natl Acad Sci, USA 100 2003 217 222
12. C.B. Lopez, B. Moltedo, L. Alexopoulou, L. Bonifaz, R.A. Flavell, and T.M. Moran TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses J Immunol 173 2004 6882 6889
13. J.H. Dufour, M. Dziejman, M.T. Liu, J.H. Leung, T.E. Lane, and A.D. Luster IFN-{gamma}-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking J Immunol 168 2002 3195 3204